Halberd Corporation’s VITA-SHIELD-MAX(TM) Immunity Support Product Shipped
Jackson Center, Pennsylvania--(Newsfile Corp. - August 9, 2021) - Halberd Corporation (OTC Pink: HALB) reports Vita-Shield-MaxTM, has been shipped! With...
News
Cardiol Therapeutics to Commence Trading on NASDAQ Under the Symbol “CRDL”
Oakville, Ontario--(Newsfile Corp. - August 9, 2021) - Cardiol Therapeutics Inc. (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage biotechnology...
Nihon Kohden to Elevate Advancements Towards Improved Patient Outcomes with the Acquisition of Advanced Medical Predictive Devices, Diagnostics and Displays, Inc.
Striving to Connect Clinicians with Intelligent Devices and Continuous Data through Predictive Algorithms IRVINE, Calif.--(BUSINESS WIRE)--Nihon Kohden, a global leader...
Dalrada Health and Vivera Pharmaceuticals Announce New Diagnostic Laboratory Joint Venture
Pala Diagnostics, a CLIA-certified state-of-the-art diagnostic laboratory will provide laboratory mobile concierge service for businesses, conventions, hospitality, and schools to...
KORU Medical Systems to Participate in Canaccord Genuity’s 41st Annual Growth Conference
CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical...
Angle PLC – Study Highlights Superior Performance of Parsortix
PUBLICATION HIGHLIGHTS EASE OF USE AND SUPERIOR PERFORMANCE OF PARSORTIX SYSTEM IN HARVESTING CTCs FROM METASTATIC BREAST CANCER PATIENTSQuantity, purity...
RELIEF THERAPEUTICS Holdings AG: Acer Therapeutics and Relief Therapeutics Announce Submission of a New Drug Application to the U.S. FDA for ACER-001 for Treatment of Urea Cycle Disorders
NEWTON, MA and GENEVA, SWITZERLAND / ACCESSWIRE / August 9, 2021 / Acer Therapeutics Inc. (NASDAQ:ACER) (" Acer "), a...
Core One Labs to Move Its Psychedelic Formulations for the Treatment of Stroke and Depression Toward Clinical Development
VANCOUVER, British Columbia, Aug. 07, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABD), (Frankfurt: LD6, WKN:...
atai Life Sciences to Present at the 41st Annual Canaccord Genuity Growth Conference
BERLIN, Aug. 06, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to...
IBA – Regulated Information
IBA – ACQUISITION OF OWN SHARES Immediate Release – August 6th, 2021 Louvain-la-Neuve, Belgium, August 6th, 2021 - In accordance...
BioVie Inc. Announces Proposed Public Offering of Common Stock
SANTA MONICA, Calif., Aug. 06, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company...
Kids and Teen Dental Place and UCLA School of Dentistry Partner With Drew Child Development Corporation to Provide 1,000 Free Fluoride Treatments at Back to School Event on August 7th
LOS ANGELES, Aug. 06, 2021 (GLOBE NEWSWIRE) -- On August 7th, Kids Dental Place and the UCLA School of Dentistry...
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
AMF REGULATED INFORMATIONMontrouge, France, August 6, 2021 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies...
Immunovant to Report Financial Results for Quarter Ended June 30, 2021
NEW YORK, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company focused on enabling normal...
Adventure Dental Vision and Orthodontics to Offer Back to School Dental and Vision Appointments in Correlation With School Supply Distribution on August 7th
SANTA FE, N.M., Aug. 06, 2021 (GLOBE NEWSWIRE) -- On August 7th, Adventure Dental, Vision and Orthodontics will be conducting...
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass., Aug. 06, 2021 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in targeted...
AB Science publishes a Q&A press release, following-up on its June 28, 2021 press release relating to an agreement with historical shareholders
PRESS RELEASE Paris, August 6 2021, 7pm AB Science SA (Euronext - FR0010557264 - AB) publishes a Q&A press release,...
Progyny, Inc. to Present at the BofA Securities SMID Cap 2H21 Ideas Conference
NEW YORK, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility...
North Bay’s Waters Edge Care Community announces new name
Residents, their families and team members instrumental in the naming processNORTH BAY, Ontario, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Waters...
FDA approves Nexviazyme® (avalglucosidase alfa-ngpt), an important new treatment option for late-onset Pompe disease
FDA approves Nexviazyme® (avalglucosidase alfa-ngpt), an important new treatment option for late-onset Pompe disease Approval is based on positive Phase...